Our team is well positioned to leverage our global resources and match emerging growth companies with high-quality financial and strategic investors. Our skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences/biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.
We have one of the financial industry’s most effective distribution platforms. This broad distribution structure creates better pricing and promotes rapid completion of transactions. Since 2009, the Maxim Merchant Capital Division has closed more than $414,000,000 in traditional private and public financings.
Using our distribution capabilities, we target a specific group of investors and organize meetings that can maximize management’s time. In our experience, an orchestrated process helps to streamline the transaction and thereby its competitiveness. A key to our success is to align ourselves with top investors, thinkers, entrepreneurs and executives around the world.